The two leading analytical approaches to metabolomics are mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy. Although currently overshadowed by MS in terms of numbers of compounds resolved, NMR spectroscopy offers advantages both on its own and coupled with MS. NMR data are highly reproducible and quantitative over a wide dynamic range and are unmatched for determining structures of unknowns. NMR is adept at tracing metabolic pathways and fluxes using isotope labels. Moreover, NMR is non-destructive and can be utilized in vivo. NMR results have a proven track record of translating in vitro findings to in vivo clinical applications. 
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Introduction
The metabolic state of an organism depends on its genome, transcriptome, proteome, epigenome, microbiome, and exposome (environment). Thus, metabolomics, the study of small molecules (<1500 Da) in living systems, provides information with a high potential for accurately describing the physiological state of an organism. The two most successful approaches to determining the metabolic state of an organism have been mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy. Several years ago, the number of publications utilizing the two approaches were comparable; more recently, however, MS-based metabolomics has clearly overtaken NMR-based metabolomics. This state of affairs prompted the organization of a workshop to review the current state of NMR-based metabolomics, to assess its strengths and weaknesses, and to envision its future potential. As reported here, this workshop ('NMRBased Metabolomics,' held in the Discovery Building, Morgridge Institute for Research, Madison, Wisconsin, USA, on June 10, 2016) highlighted a number of benefits of NMR-based metabolomics that appear to be currently underappreciated. MS and NMR offer different strengths, which can be used synergistically. The workshop stressed the need for more extensive small molecule databases and improved standards at each step of a metabolomics study.
The metabolome
The two major fields of chemical research on biological small molecules, metabolomics and natural product discovery, have the similar goals of identifying and characterizing small molecules, either in their isolated active state (natural product chemistry) or as mixtures (metabolomics) [1] . The number of small molecules of importance to humans is far greater than those currently represented on metabolic charts, with the excess constituting current 'metabolic dark matter' (Figure 1 ). The swapping of metabolites between pathways in humans and those of organisms in the human microbiome increases the network of relevant reactions by a staggering amount. The HMDB [2] lists 42 000 metabolites and the number of lipid variants is on the order of 100 000; thus, a lower limit of expected endogenous and exogenous human metabolites is around 150 000, but the actual number of metabolites could be much higher. Of this vast number of metabolites, only 1500 may be identified from global profiling, 200-500 from targeted profiling, and far fewer are routinely subjected to quantitative analysis. offers a window into observing and rigorously quantifying all of the more abundant compounds present in biological fluids, cell extracts, and tissues without the need for elaborate sample preparation or fractionation. NMR offers advantages for compounds that are difficult to ionize or require derivatization for MS. NMR allows the identification of compounds with identical masses, including those with different isotopomer distributions. NMR is the mainstay for determining structures of unknown compounds. Through the use of stable isotope labels, NMR can be used to elucidate the dynamics and mechanisms of metabolite transformations and to explore the compartmentalization of metabolic pathways. NMR has advantages in drug screening [5] . Finally, site-specific NMR imaging and spectroscopy offer approaches for metabolic studies in living organisms.
Strategies for the identification of metabolites in complex mixtures from NMR data have been reviewed recently [6 ] . The most important nuclei in biomolecular NMR studies are 1 H (proton), 13 
Combining NMR and MS
As reviewed recently [26 ] , advances in NMR-based and MS-based metabolomics, including the combination of the two approaches, promise to greatly improve the identification and quantitation of compounds in mixtures. One example is the simultaneous analysis of DI-ESI-MS and 1D
1 H NMR spectral data to yield accurate mass measurements and class separation scores [27] . Other approaches filter data from one approach against the other to increase the number of compounds confidently identified [28 ,29 ] . Another method identifies compounds by exploiting the principle that abundance/intensity ratios are relatively constant for the same metabolite in different samples [30] . Combined NMR and MS has advantages for isotope tracing experiments and metabolic flux analysis. MS generally quantifies isotopic labeling distributions but even with MS/MS often does not give the specific labeling position, which is available from NMR.
Quantification

If 1D
1 H NMR peaks from a compound are well resolved with acceptable signal-to-noise, their intensities correlate linearly with its relative concentration. To determine absolute concentrations, one adds a standard of known concentration. The cross peak intensities of the same 2D 1 H-13 C HSQC spectrum, however, do not correlate linearly with concentration. One can collect spectra of mixtures with known concentrations bracketing those of the unknowns and use these to determine factors that translate peak intensity to concentration [31] . Peak intensities in 2D 1 H-13 C HSQC spectra can also be converted to concentration from the slopes generated by spectra utilizing different replicates of the pulse sequence module and the linear extrapolation back to zero time of the peak intensities following the delays from one and two modules yields the 'HSQC 0 spectrum' whose peak intensities are proportional to concentration [32] . Spectral overlaps can be accounted for by methods such as FMLR (fast maximum-likelihood reconstruction) [33] . A new experiment ( 1 H-13 C QUIPU HSQC) aims to quantify in one map a complex mixture composed of low concentrated metabolites [34] . Another approach, one that requires full 13 C labeling, achieves quantification through the collection of 13 C-13 C CT-TOCSY spectra and the application of analytical approximations based on the known carbonbackbone topologies [35] .
Applications of metabolomics
Applications of metabolomics include disease diagnosis, monitoring the effects of medical interventions including drugs, detection of adulteration of food, and analysis of biochemical pathways and their perturbations resulting from mutations, aging, diet, exercise, or life style. A recent study showed how ex vivo 1D 1 H NMR spectroscopy can be used for the simultaneous identification and quantification of co-enzymes that report on cellular function [36 ] . Another study used this approach to investigate alterations in the energy/redox-metabolome in dopaminergic cells exposed to environmental/mitochondrial toxins [37] . Studies of the metabolomics of model organisms are both timely and important for understanding of their different biology [38 ] . Protocols have been described for studies of the metabolomics of bacteria [39] and plants [40] . Metabolomics, along with activity-guided fractionation followed by structural analysis, constitutes a powerful approach for identifying biologically active compounds for studies in chemical ecology [41 ] . Metabolomics is used regularly in drug discovery programs to uncover the efficacy, specificity, or toxicity of lead compounds [42] . Metabolomics can provide information on the in vivo mechanism of action and to eliminate compounds likely to cause problems with side effects [43 ] . Recent studies have utilized metabolomics to search for biomarkers for colon cancer [44] and multiple sclerosis [45] .
Future technology
All technologies that increase NMR sensitivity are of extreme importance as are improvements in sample preparation [46 ] . Approaches to high sensitivity include NMR spectrometers with ultra-high-field magnets operating at 1 H resonance frequencies of 1.2 GHz or higher. The first such systems are scheduled for delivery in 2017. Small high-temperature superconducting coils can maximize the signal per sample mass: a 13 C-optimized 1.5-mm high temperature superconducting NMR probe has enabled novel 13 C NMR studies of natural products [47] , and this has been followed up with a 1 H-13 C dual-optimized NMR probe based on doubletuned high temperature superconducting resonators [48 ] . These probes take advantage of the excellent peak dispersion of 13 Hyperpolarization offers an approach for enhanced sensitivity with even higher potential. The underlying physics utilizes the magnetic moment of the unpaired electron, which is roughly 2800 times that of 13 
Conclusions
The workshop demonstrated that NMR-based metabolomics promises to continue to play an important role in the studies of complex mixtures of small biological molecules, their metabolic networks, and their interactions with biomacromolecules. Although the development of new and better methods continues to be an integral part, the field needs to focus on developing standardized, enlarged, and integrated databases of NMR data on small molecules as well as archives representing the NMR metabolic fingerprints of standard biological fluids and tissue extracts from humans and model organisms. Standardization of best practices for sample preparation, data collection and analysis should enhance the reproducibility of results within the metabolomics community, while at the same time avoiding the risk of adhering to methods and protocols that are suboptimal in a field that is very much in flux. In order to overcome skepticism in omics [53 ] , it will be advisable for metabolomics to build the ideas of reproducibility and data sharing into every tool and database. Future work is expected to build upon core strengths of NMR spectroscopy, which includes its versatility and specificity in the form of 1D and higher dimensional spectra, its reproducibility, its quantitative ability, its capability for following chemical reactions and flux, its ability to identify compounds and deduce structures of unknowns, and its growing potential for collecting metabolomics data in vivo. 21. Nagana Gowda GA, Gowda YN, Raftery D: Massive glutamine cyclization to pyroglutamic acid in human serum discovered using NMR spectroscopy. Anal Chem 2015, 87:3800-3805.
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